CLNN

Clene (CLNN)

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high
$6.24
Daily low
$6.00
Price at open
$6.24
52 Week High
$13.50
52 Week Low
$2.28
Market cap
64.5M
Dividend yield
0.00%
Volume
9,519
Avg. volume
327,993
P/E ratio
-1.84

Clene News

Details

Daily high
$6.24
Daily low
$6.00
Price at open
$6.24
52 Week High
$13.50
52 Week Low
$2.28
Market cap
64.5M
Dividend yield
0.00%
Volume
9,519
Avg. volume
327,993
P/E ratio
-1.84